Literature DB >> 30080294

Milk thistle (Silybum marianum): A concise overview on its chemistry, pharmacological, and nutraceutical uses in liver diseases.

Ludovico Abenavoli1, Angelo A Izzo2, Natasa Milić3, Carla Cicala2, Antonello Santini2, Raffaele Capasso4.   

Abstract

Milk thistle (MT; Silybum marianum), a member of the Asteraceae family, is a therapeutic herb with a 2,000-year history of use. MT fruits contain a mixture of flavonolignans collectively known as silymarin, being silybin (also named silibinin) the main component. This article reviews the chemistry of MT, the pharmacokinetics and bioavailability, the pharmacologically relevant actions for liver diseases (e.g., anti-inflammatory, immunomodulating, antifibrotic, antioxidant, and liver-regenerating properties) as well as the clinical potential in patients with alcoholic liver disease, nonalcoholic fatty liver disease, viral hepatitis, drug-induced liver injury, and mushroom poisoning. Overall, literature data suggest that, despite encouraging preclinical data, further well-designed randomized clinical trials are needed to fully substantiate the real value of MT preparations in liver diseases.
© 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  liver fibrosis; oxidative stress; silybin; silymarin

Mesh:

Substances:

Year:  2018        PMID: 30080294     DOI: 10.1002/ptr.6171

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  65 in total

Review 1.  Prevalence and current therapy in chronic liver disorders.

Authors:  Muhammad Daniyal; Muhammad Akram; Rida Zainab; Naveed Munir; Aamir Sharif; Syed Muhammad Ali Shah; Bin Liu; Wei Wang
Journal:  Inflammopharmacology       Date:  2019-02-08       Impact factor: 4.473

2.  Silymarin suppresses HepG2 hepatocarcinoma cell progression through downregulation of Slit-2/Robo-1 pathway.

Authors:  Nuriye Ezgi Bektur Aykanat; Sedat Kacar; Serife Karakaya; Varol Sahinturk
Journal:  Pharmacol Rep       Date:  2020-01-08       Impact factor: 3.024

Review 3.  Antidiabetic Potential of Medicinal Plants and Their Active Components.

Authors:  Bahare Salehi; Athar Ata; Nanjangud V Anil Kumar; Farukh Sharopov; Karina Ramírez-Alarcón; Ana Ruiz-Ortega; Seyed Abdulmajid Ayatollahi; Patrick Valere Tsouh Fokou; Farzad Kobarfard; Zainul Amiruddin Zakaria; Marcello Iriti; Yasaman Taheri; Miquel Martorell; Antoni Sureda; William N Setzer; Alessandra Durazzo; Massimo Lucarini; Antonello Santini; Raffaele Capasso; Elise Adrian Ostrander; Muhammad Iqbal Choudhary; William C Cho; Javad Sharifi-Rad
Journal:  Biomolecules       Date:  2019-09-30

4.  Single Laboratory Validation of UHPLC-MS/MS Assays for Six Milk Thistle Flavonolignans in Human Serum.

Authors:  Ruth N Muchiri; Richard B van Breemen
Journal:  J AOAC Int       Date:  2021-03-05       Impact factor: 1.913

5.  Chitosan Elicitation Impacts Flavonolignan Biosynthesis in Silybum marianum (L.) Gaertn Cell Suspension and Enhances Antioxidant and Anti-Inflammatory Activities of Cell Extracts.

Authors:  Muzamil Shah; Hasnain Jan; Samantha Drouet; Duangjai Tungmunnithum; Jafir Hussain Shirazi; Christophe Hano; Bilal Haider Abbasi
Journal:  Molecules       Date:  2021-02-03       Impact factor: 4.411

Review 6.  Phyto-pharmacological perspective of Silymarin: A potential prophylactic or therapeutic agent for COVID-19, based on its promising immunomodulatory, anti-coagulant and anti-viral property.

Authors:  Partha Palit; Aparna Mukhopadhyay; Debprasad Chattopadhyay
Journal:  Phytother Res       Date:  2021-04-04       Impact factor: 6.388

Review 7.  Plant-Based Foods and Their Bioactive Compounds on Fatty Liver Disease: Effects, Mechanisms, and Clinical Application.

Authors:  Hang-Yu Li; Ren-You Gan; Ao Shang; Qian-Qian Mao; Quan-Cai Sun; Ding-Tao Wu; Fang Geng; Xiao-Qin He; Hua-Bin Li
Journal:  Oxid Med Cell Longev       Date:  2021-03-01       Impact factor: 6.543

8.  Antioxidant Effects and Phytochemical Properties of Seven Taiwanese Cirsium Species Extracts.

Authors:  Zi-Wei Zhao; Hung-Chi Chang; Hui Ching; Jin-Cherng Lien; Hui-Chi Huang; Chi-Rei Wu
Journal:  Molecules       Date:  2021-06-28       Impact factor: 4.411

Review 9.  Lung Cancer Management with Silibinin: A Historical and Translational Perspective.

Authors:  Sara Verdura; Elisabet Cuyàs; Verónica Ruiz-Torres; Vicente Micol; Jorge Joven; Joaquim Bosch-Barrera; Javier A Menendez
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-11

10.  The effect of silymarin on liver enzymes and antioxidant status in trauma patients in the intensive care unit: a randomized double blinded placebo-controlled clinical trial.

Authors:  Ehsan Mirzaei; Golnar Sabetian; Mansoor Masjedi; Reza Heidari; Mahtabalsadat Mirjalili; Amirreza Dehghanian; Afsaneh Vazin
Journal:  Clin Exp Hepatol       Date:  2021-06-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.